Image
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
The EncircleRxSM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM.
Despite inflation and price hikes across many commonly used drugs, the employer-sponsored insurance market continues to deliver meaningful stability – and even savings – thanks to strong cost management strategies.